Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Clopidogrel pre-treatment before planned percutaneous coronary intervention was proved to
reduce periprocedural complications. However, the vast majority of patients in the current
interventional cardiology practice do not undergo planned PCI, but rather "ad-hoc" PCI
performed immediately after coronary angiography . Whether clopidogrel should be administered
as pre-treatment to all patients undergoing elective CAG with the aim to ensure therapeutic
levels at the time of possible ad-hoc PCI is not known.